These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8856146)

  • 1. Comparative profile of novel potent bradykinin antagonists at human B1 and B2 receptors.
    Burkard M; Zuzack JS; Jones S; Francis M; Whalley ET; Stewart JM; Gera L
    Immunopharmacology; 1996 Jun; 33(1-3):186-90. PubMed ID: 8856146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors.
    Hanson WL; McCullough RG; Selig WM; Wieczorek M; Ross S; Whalley ET; Stewart JM; Gera L
    Immunopharmacology; 1996 Jun; 33(1-3):191-3. PubMed ID: 8856147
    [No Abstract]   [Full Text] [Related]  

  • 3. A new class of potent bradykinin antagonist dimers.
    Gera L; Stewart JM; Whalley E; Burkard M; Zuzack JS
    Immunopharmacology; 1996 Jun; 33(1-3):178-82. PubMed ID: 8856144
    [No Abstract]   [Full Text] [Related]  

  • 4. New bradykinin antagonists having very high potency at B1 receptors.
    Gera L; Stewart JM; Whalley ET; Burkard M; Zuzack JS
    Immunopharmacology; 1996 Jun; 33(1-3):183-5. PubMed ID: 8856145
    [No Abstract]   [Full Text] [Related]  

  • 5. Inducible bradykinin B1 receptor in isolated human ileum.
    Zuzack JS; Burkard MR; Cuadrado DK; Greer RA; Selig WM; Whalley ET
    Immunopharmacology; 1996 Jun; 33(1-3):113-5. PubMed ID: 8856127
    [No Abstract]   [Full Text] [Related]  

  • 6. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
    J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new generation of bradykinin antagonists.
    Stewart JM; Gera L; Hanson W; Zuzack JS; Burkard M; McCullough R; Whalley ET
    Immunopharmacology; 1996 Jun; 33(1-3):51-60. PubMed ID: 8856115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
    Meini S; Lecci A; Maggi CA
    Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
    Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
    Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of bradykinin antagonists containing indanylglycine.
    Gera L; Stewart JM
    Immunopharmacology; 1996 Jun; 33(1-3):174-7. PubMed ID: 8856143
    [No Abstract]   [Full Text] [Related]  

  • 12. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
    Butt SK; Dawson LG; Hall JM
    Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-selectivity of new bradykinin antagonists for B1 receptors.
    Rhaleb NE; Gobeil F; Regoli D
    Life Sci; 1992; 51(11):PL125-9. PubMed ID: 1326066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent, long-acting bradykinin antagonists for a wide range of applications.
    Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
    Can J Physiol Pharmacol; 1997 Jun; 75(6):719-24. PubMed ID: 9276154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
    Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
    Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344.
    Inamura N; Asano M; Hatori C; Sawai H; Hirosumi J; Fujiwara T; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Oku T; Nakahara K
    Eur J Pharmacol; 1997 Aug; 333(1):79-86. PubMed ID: 9311664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists for kinin B1 and B2 receptors in the mouse.
    Nsa Allogho S; Gobeil F; Pheng LH; Nguyen-Le XK; Neugebauer W; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):558-62. PubMed ID: 9276128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors for kinins: from classical pharmacology to molecular biology.
    Regoli D; Pheng LH; Allogho SN; Nguyen-Le XK; Gobeil F
    Immunopharmacology; 1996 Jun; 33(1-3):116-22. PubMed ID: 8856128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DesArg10[Hoe 140] is a potent B1 bradykinin antagonist.
    Wirth KJ; Wiemer G; Schölkens BA
    Agents Actions Suppl; 1992; 38 ( Pt 2)():406-13. PubMed ID: 1334341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effects of the new nonpeptide bradykinin B2 receptor antagonist, LF 16-0335C, on guinea-pig and rat kinin receptors.
    Pruneau D; Luccarini JM; Fouchet C; Defrêne E; Franck RM; Loillier B; Duclos H; Robert C; Cremers B; Bélichard P; Paquet JL
    Fundam Clin Pharmacol; 1999; 13(1):75-83. PubMed ID: 10027091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.